AGPYY yields 124.22% · PFE yields 6.13%● Live data
📍 AGPYY pulled ahead of the other in Year 1
Combined, AGPYY + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of AGPYY + PFE for your $10,000?
Agile Group Holdings Limited, an investment holding company, engages in the property development, property management, hotel operation, property investment, environmental protection, and other businesses in the People's Republic of China. As of December 31, 2021, the company had a land bank with a total gross floor area of 47.37 million square meters in 84 cities located in Southern China region, Eastern China region, Western China region, Central China region, Hainan and Yunnan region, Northeast China region, Northern China region, Hong Kong, and internationally. It also provides property management services, as well as residential property management, asset management, public property management, civil services, and community business. In addition, the company provides operation of ecological industrial park, hazardous waste treatment, and daily waste treatment to commercial food waste treatment; and sludge treatment, soil treatment, and water restoration to sewage treatment, and water affairs. The company was formerly known as Agile Property Holdings Limited and changed its name to Agile Group Holdings Limited in July 2016. The company was incorporated in 2005 and is headquartered in Guangzhou, the People's Republic of China. Agile Group Holdings Limited is a subsidiary of Top Coast Investment Limited.
Full AGPYY Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.